PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
Clinical trial NCT04517864 · TERMINATED
Trial details
- NCT number
- NCT04517864
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2022-01-04
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.